Chloroquine retinopathy: is there a safe daily dose?
Open Access
- 1 February 1982
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 41 (1) , 52-58
- https://doi.org/10.1136/ard.41.1.52
Abstract
Published case reports of chloroquine retinopathy rarely include details of daily dosage, but 30 reports where this information was available included 78 patients who developed impaired visual acuity an 13 had received daily doses of 250 mg or less. Eleven cases of ocular toxicity attributed to chloroquine were reported to the Committee on Safety of Medicines but only 2 developed impaired vision on 250 mg daily. A postal questionnaire among 41 rheumatology and 33 ophthalmology centres showed 2 patients who developed impaired vision as a result of treatment with chloroquine in a daily dose not exceeding 250 mg. Serious visual impairment related to chloroquine rarely occurs if the daily dose does not exceed 250 mg.This publication has 51 references indexed in Scilit:
- RETINAL AND VISUAL FIELD CHANGES IN CHLOROQUINE RETINOPATHYActa Ophthalmologica, 2009
- IS CHLOROQUINE OBSOLETE IN TREATMENT OF RHEUMATIC DISEASE?The Lancet, 1979
- Variations in the normal electro-oculogram.British Journal of Ophthalmology, 1967
- THREE CASES OF CHLOROQUINE RETINOPATHY A FOLLOW‐UP INVESTIGATIONActa Ophthalmologica, 1966
- SCREENING TEST FOR CHLOROQUINE RETINOPATHYThe Lancet, 1964
- RETINAL DAMAGE IN CHLOROQUINE THERAPYActa Ophthalmologica, 1963
- ELECTRORETINOGRAPHIC CHANGES IN CHLOROQUINE THERAPYActa Ophthalmologica, 1962
- ELECTRORETINOGRAPHIC EXAMINATIONS FOLLOWING THE APPLICATION OF CHLOROQUINEActa Ophthalmologica, 1962
- Two Cases of Chloroquine-induced Retinal DamageBMJ, 1962
- Chloroquine Diphosphate in Rheumatoid ArthritisAnnals of the Rheumatic Diseases, 1961